CIK 0001401040 · Non-accelerated filer<br>Smaller reporting company
DiaMedica Therapeutics Inc.
Sign in to watch- Ticker
- DMAC
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- Canada (Federal Level)
- Entity type
- operating
- Phone
- (763) 496-5454
- Business address
- 301 CARLSON PARKWAY, SUITE 210, MINNEAPOLIS, MN, 55305
- Former names
- DiaMedica Inc.
- 10-K Report Annual Report
- SCHEDULE 13G/A Stake Statement of Beneficial Ownership
- SCHEDULE 13G/A Stake Statement of Beneficial Ownership
- SCHEDULE 13G/A Stake Statement of Beneficial Ownership
- 4 Grant or award Director acquired 10,095 shares (grant or award)
- 4 Grant or award Director acquired 6,175 shares (grant or award)
- 4 Grant or award Director acquired 3,355 shares (grant or award)
- 8-K Event Other events
- 8-K Event Regulation FD disclosure · Other events
- 4 Open-market buy 10% owner bought 1,061,277 shares at an average $7.19 ($7,631,469)
- 4 Option exercise Director acquired 12,000 shares (option exercise)
- S-8 Other Securities Offered to Employees in Benefit Plans
- 10-Q Report Quarterly Report
- 8-K Event Results of operations
- SCHEDULE 13G/A Stake Statement of Beneficial Ownership
- 4 Derivatives Options or other derivatives
- 3 Insider Initial Statement of Ownership
- SCHEDULE 13G/A Stake Statement of Beneficial Ownership
- 4 Open-market buy 10% owner bought 1,000,000 shares at an average $5.96 ($5,958,107)
- SCHEDULE 13G/A Stake Statement of Beneficial Ownership
Page 2 of 22 · 427 filings